NCT02072265

Brief Summary

Permanently implantable venous ports (Port-A) is very important to patients receiving chemotherapy. It not only provides a reliable route to administrate intravenous drugs, and it also requires minimal care when it is not in use. However, catheter related blood stream infection(CRBSI) is one of the serious complications of Port-A. The diagnosis of CRBSI relies on limited tools, including blood culture or symptoms and signs of active infection. In the stage of CRBSI, Port-A removal is necessary and pose the risk for the patients to re-implant the Port-A. Thus, it is crucial to early detect the infection and give appropriate treatment. Among the pathogens, some pathogens are related to skin contaminants. Before systemic spreading, these pathogens may colonize or cause minor infection subcutaneously. This investigation is to utilize a non-invasive dual spectrum infrared imaging system to evaluate the Port-A wound and to detect the infection. Aim: 1. To build the database of infra-red thermal images of Port-A wound healing. 2. To investigate the thermal images of skin contamination related CRBSI and to compare with the thermal images of the CRBSI of unknown foci

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2014

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 26, 2014

Completed
3 days until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Last Updated

February 26, 2014

Status Verified

February 1, 2014

Enrollment Period

8 months

First QC Date

February 12, 2014

Last Update Submit

February 24, 2014

Conditions

Keywords

infrared thermal imagewound healingwound infection

Outcome Measures

Primary Outcomes (4)

  • Port-A wound healing/infection status (infrared thermal images)

    The patient will be followed once about 1 day before stitches removal of the port-A wound.

  • Port-A wound healing/infection status (infrared thermal images)

    The patient will be followed once about 6 to 24 hours before the first chemotherapy

  • Port-A wound healing/infection status (infrared thermal images)

    The patient will be followed once about 6 to 24 hours before the second chemotherapy

  • Port-A wound healing/infection status (infrared thermal images)

    The patient will be followed once about 1 day before Port-A removal due to infection

Study Arms (2)

Port-A implantation and chemotherapy

Patients scheduled for Port-A implantation and subsequent chemotherapy

Device: Infrared thermal images

Port-A infection

Patients receiving Port-A removal due to infection

Device: Infrared thermal images

Interventions

Port-A implantation and chemotherapyPort-A infection

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients receiving Port-A implantation and removal

You may qualify if:

  • clinical requirement of chemotherapy with Port-A

You may not qualify if:

  • not able to maintain posture during acquiring the thermal images
  • with other wounds over the nearby area of the Port-A wound
  • with other severe underlying disease and too weak to mobilize

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Wound Infection

Condition Hierarchy (Ancestors)

Infections

Central Study Contacts

Po-Yuan Shih, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2014

First Posted

February 26, 2014

Study Start

March 1, 2014

Primary Completion

November 1, 2014

Last Updated

February 26, 2014

Record last verified: 2014-02

Locations